Gilead, Bris­tol My­ers face law­suit from ma­jor phar­ma­cies over HIV gener­ic drug de­lays

Ma­jor phar­ma­cy chains CVS and Rite Aid re­cent­ly sued Gilead Sci­ences, Te­va and Bris­tol My­ers Squibb, claim­ing the phar­ma com­pa­nies de­lib­er­ate­ly stalled the in­tro­duc­tion of cheap­er gener­ic ver­sions of sev­er­al block­buster HIV drugs.

The suit specif­i­cal­ly goes af­ter bil­lions of dol­lars worth of re­verse-pay­ment agree­ments be­tween the phar­ma com­pa­nies that with­held from the mar­ket gener­ic ver­sions of HIV drugs Viread, Atripla, Tru­va­da and Evotaz.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER